• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合证理论和高通量表达数据预测中药方剂的新作用。

Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae.

机构信息

College of Life Science and Biotechnology, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China.

出版信息

Evid Based Complement Alternat Med. 2012;2012:986427. doi: 10.1155/2012/986427. Epub 2012 May 14.

DOI:10.1155/2012/986427
PMID:22666299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3359832/
Abstract

ZHENG is the key theory in traditional Chinese medicine (TCM) and it is very important to find the molecular pharmacology of traditional Chinese herbal formulae. One ZHENG is related to many diseases and the herbal formulae are aiming to ZHENG. Therefore, many herbal formulae whose effects on a certain disease have been confirmed might also treat other diseases with the same ZHENG. In this study, the microarrays collected from patients with QiXuXueYu ZHENG (Qi-deficiency and Blood-stasis syndrome) before treatment and after being treated with Fuzheng Huayu Capsule were analyzed by a high-throughput gene microarrays-based drug similarity comparison method, which could find the small molecules which had similar effects with Fuzheng Huayu Capsule. Besides getting the results of anti-inflammatory and anti-fibrosis drugs which embody the known effect of Fuzheng Huayu Capsule, many other small molecules were screened out and could reflect other types of effects of this formula in treating QiXuXueYu ZHENG, including anti-hyperglycemic, anti-hyperlipidemic, hyposenstive effect. Then we integrated this information to display the effect of Fuzheng Huayu Capsule and its potential multiple-target molecular pharmacology. Moreover, through using clinical blood-tested data to verify our prediction, Fuzheng Huayu Capsule was proved to have effects on diabetes and dyslipidemia.

摘要

“证”是中医理论的关键,寻找中药复方的分子药理学非常重要。一个“证”与许多疾病有关,而中药复方则针对“证”。因此,许多已证实对某种疾病有效的确证中药复方,也可能对具有相同“证”的其他疾病进行治疗。在这项研究中,我们通过高通量基因芯片药物相似性比较方法,分析了治疗气虚血瘀证患者在治疗前后的微阵列,找到了与扶正化瘀胶囊具有相似作用的小分子。除了得到体现扶正化瘀胶囊已知作用的抗炎和抗纤维化药物的结果外,还筛选出许多其他小分子,反映了该方剂治疗气虚血瘀证的其他类型作用,包括降血糖、降血脂、降血压作用。然后,我们整合这些信息,以显示扶正化瘀胶囊的作用及其潜在的多靶点分子药理学。此外,通过使用临床血液测试数据来验证我们的预测,证明扶正化瘀胶囊对糖尿病和血脂异常有作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/8665b7c31902/ECAM2012-986427.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/909848e1c201/ECAM2012-986427.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/6cf7a24c1d70/ECAM2012-986427.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/150fcf87ad7a/ECAM2012-986427.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/8665b7c31902/ECAM2012-986427.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/909848e1c201/ECAM2012-986427.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/6cf7a24c1d70/ECAM2012-986427.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/150fcf87ad7a/ECAM2012-986427.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/3359832/8665b7c31902/ECAM2012-986427.004.jpg

相似文献

1
Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae.结合证理论和高通量表达数据预测中药方剂的新作用。
Evid Based Complement Alternat Med. 2012;2012:986427. doi: 10.1155/2012/986427. Epub 2012 May 14.
2
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
3
[Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis].益气活血方治疗慢性病毒性肝炎肝纤维化的临床研究
Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):403-409. doi: 10.3760/cma.j.cn501113-20190905-00325.
4
Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis.肝郁脾虚证是乙肝相关肝纤维化患者对恩替卡韦+扶正化瘀治疗反应的主要中医证候。
Heliyon. 2023 Nov 13;9(11):e22216. doi: 10.1016/j.heliyon.2023.e22216. eCollection 2023 Nov.
5
Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis.扶正化瘀胶囊联合派罗欣对1型丙型肝炎纤维化及细胞凋亡的影响
Exp Ther Med. 2014 Oct;8(4):1123-1126. doi: 10.3892/etm.2014.1891. Epub 2014 Aug 8.
6
[Effects of Chinese herbal medicine Fuzheng Huayu recipe and its components against hepatocyte apoptosis in mice with hepatic injury].[中药扶正化瘀方及其成分对肝损伤小鼠肝细胞凋亡的影响]
Zhong Xi Yi Jie He Xue Bao. 2011 Jan;9(1):57-63. doi: 10.3736/jcim20110110.
7
[Prevention and Therapeutic Effects of Fuzheng Huayu Capsule on Liver Fibrosis and Expression of Connective Tissue Growth Factor in Rats].扶正化瘀胶囊对大鼠肝纤维化及结缔组织生长因子表达的防治作用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 Mar;47(2):197-202.
8
[Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis].扶正化瘀胶囊对肝硬化患者生存率的影响
Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):834-840. doi: 10.3760/cma.j.issn.1007-3418.2017.11.007.
9
Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.基于证型的扶正化瘀片对 CYP1A2 基因多态性相关乙型肝炎肝硬化的疗效。
Evid Based Complement Alternat Med. 2013;2013:302131. doi: 10.1155/2013/302131. Epub 2013 Oct 24.
10
[Curative effects of Fuzheng Huayu capsules on hepatic fibrosis and the functional mechanisms: a review].扶正化瘀胶囊对肝纤维化的疗效及作用机制:综述
Zhong Xi Yi Jie He Xue Bao. 2006 Sep;4(5):467-72. doi: 10.3736/jcim20060505.

引用本文的文献

1
Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of L. and the Toxicity-Reducing Effect of Processing.代谢组学揭示了百合的肺毒性机制及炮制的减毒作用。
Front Pharmacol. 2021 Aug 9;12:630319. doi: 10.3389/fphar.2021.630319. eCollection 2021.
2
The Advantages of Connectivity Map Applied in Traditional Chinese Medicine.连通性图谱应用于中医药的优势
Front Pharmacol. 2021 Mar 11;12:474267. doi: 10.3389/fphar.2021.474267. eCollection 2021.
3
Metabolomics reveals the mechanisms for the cardiotoxicity of Pinelliae Rhizoma and the toxicity-reducing effect of processing.

本文引用的文献

1
Network target for screening synergistic drug combinations with application to traditional Chinese medicine.用于筛选协同药物组合的网络靶点及其在中药中的应用
BMC Syst Biol. 2011 Jun 20;5 Suppl 1(Suppl 1):S10. doi: 10.1186/1752-0509-5-S1-S10.
2
The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.罗格列酮和二甲双胍对 2 型糖尿病患者炎症和内皮功能障碍的影响。
Acta Diabetol. 2011 Dec;48(4):297-302. doi: 10.1007/s00592-011-0276-y. Epub 2011 Mar 23.
3
Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
代谢组学揭示了半夏的心脏毒性机制及其炮制减毒作用。
Sci Rep. 2016 Oct 4;6:34692. doi: 10.1038/srep34692.
4
Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis.黄芪汤对大鼠肝纤维化的作用:基因表达谱分析
Chin Med. 2015 Dec 18;10:39. doi: 10.1186/s13020-015-0066-5. eCollection 2015.
5
Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis.扶正化瘀对肝纤维化和肝硬化的疗效:一项荟萃分析
Evid Based Complement Alternat Med. 2015;2015:125659. doi: 10.1155/2015/125659. Epub 2015 Jun 28.
6
A network-based systematic study for the mechanism of the treatment of zhengs related to cough variant asthma.基于网络的系统研究镇咳相关变异性哮喘的治疗机制。
Evid Based Complement Alternat Med. 2013;2013:595924. doi: 10.1155/2013/595924. Epub 2013 Nov 28.
7
Yu Ping Feng San, an ancient Chinese herbal decoction containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, regulates the release of cytokines in murine macrophages.玉屏风散,一种含有黄芪、白术和防风的中药方剂,可调节小鼠巨噬细胞细胞因子的释放。
PLoS One. 2013 Nov 11;8(11):e78622. doi: 10.1371/journal.pone.0078622. eCollection 2013.
8
Clinical Applications of Omics Technologies on ZHENG Differentiation Research in Traditional Chinese Medicine.组学技术在中医“证”研究中的临床应用。
Evid Based Complement Alternat Med. 2013;2013:989618. doi: 10.1155/2013/989618. Epub 2013 Jun 18.
9
Network pharmacology: a new approach for chinese herbal medicine research.网络药理学:中药研究的新途径。
Evid Based Complement Alternat Med. 2013;2013:621423. doi: 10.1155/2013/621423. Epub 2013 May 20.
染料木黄酮通过高脂肪饮食诱导的非酒精性脂肪性肝炎大鼠的抗炎作用及其潜在机制。
Int Immunopharmacol. 2011 Jun;11(6):762-8. doi: 10.1016/j.intimp.2011.01.036. Epub 2011 Feb 12.
4
Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae.草药网络构建与共模块分析揭示中药方剂的组合规律。
BMC Bioinformatics. 2010 Dec 14;11 Suppl 11(Suppl 11):S6. doi: 10.1186/1471-2105-11-S11-S6.
5
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.mTOR 抑制剂西罗莫司和依维莫司具有很强的抗纤维化活性,但环孢素 A 和他克莫司则没有这种活性,在实验性肝纤维化中。
J Hepatol. 2011 Aug;55(2):388-98. doi: 10.1016/j.jhep.2010.10.044. Epub 2010 Dec 17.
6
Verapamil block of T-type calcium channels.维拉帕米对 T 型钙通道的阻断作用。
Mol Pharmacol. 2011 Mar;79(3):411-9. doi: 10.1124/mol.110.069492. Epub 2010 Dec 13.
7
Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell.中医类风湿关节炎的寒与热证型:通过 CD4 阳性 T 细胞的基因表达谱芯片鉴定出的独特分子特征。
Rheumatol Int. 2012 Jan;32(1):61-8. doi: 10.1007/s00296-010-1546-7. Epub 2010 Jul 25.
8
Application of connectivity mapping in predictive toxicology based on gene-expression similarity.基于基因表达相似性的连接图在预测毒理学中的应用。
Toxicology. 2010 Feb 9;268(3):143-6. doi: 10.1016/j.tox.2009.09.014. Epub 2009 Sep 27.
9
Effect of Fuzheng Huayu formula and its actions against liver fibrosis.扶正化瘀方及其抗肝纤维化作用。
Chin Med. 2009 Jun 29;4:12. doi: 10.1186/1749-8546-4-12.
10
Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment.临床实践中的整合医学:从中医辨证论治到疾病治疗
Chin J Integr Med. 2009 Apr;15(2):152. doi: 10.1007/s11655-009-0152-6. Epub 2009 Apr 29.